Myr (MYRG) EBITDA Margin (2010 - 2026)

Myr has disclosed EBITDA Margin across 17 years of filings, most recently posting 4.55% for Q1 2026.

• In Q1 2026, EBITDA Margin rose 174.0% year-over-year to 4.55%; the TTM figure through Mar 2026 stood at 3.79% (up 295.0% YoY), while the FY2025 annual figure was 3.36%, up 272.0% from the prior year.
• EBITDA Margin advanced to 4.55% in Q1 2026, from 3.88% in the prior quarter.
• Over the last five years, EBITDA Margin for MYRG reached as high as 4.55% in Q1 2026 and fell as low as 1.98% in Q2 2024.
• The 5-year median for EBITDA Margin is 2.75% (2023), against an average of 2.42%.
• Annual changes were most pronounced in 2024 — EBITDA Margin sank 473 bps — and 2025, when it soared 547 bps.
• A 5-year view of EBITDA Margin shows it stood at 2.99% in 2022, then slipped by 11 bps to 2.67% in 2023, then slumped by 57 bps to 1.15% in 2024, then surged by 239 bps to 3.88% in 2025, then grew by 17 bps to 4.55% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 4.55%, 3.88%, and 3.19% for Q1 2026, Q4 2025, and Q3 2025 respectively.